IP Library › Granted Patent US 7,772,404
Granted Patent B2
US 7,772,404 · App. 12/251,918 · Granted Aug 10, 2010

Crystalline form 2 of the chemotherapeutic N-[4-(3-amino-1H-indazol-4-yl)phenyl]-N′-(2-fluoro-5-methylphenyl)urea

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,772,404
App. No.
12/251,918
Granted
Aug 10, 2010
Kind
B2
Abstract

N-[4-(3-Amino-1H-indazol-4-yl)phenyl]-N′-(2-fluoro-5-methylphenyl)urea Crystalline Form 2, ways to make it, formulations comprising it and made with it and methods of treating patients having disease using it are disclosed.

Claims (1)

1. N-[4-(3-Amino-1H-indazol-4-yl)phenyl]-N′-(2-fluoro-5-methylphenyl)urea Crystalline Form 2 which, when measured at about 25° C. with radiation at a wavelength of 1.54178 Angstroms, is characterized by a powder diffraction pattern having respective 2θ values of about 6.7°, 10.1°, 11.8°, 13.4°, 14.40°, 15.4°, 16.6°, 16.8°, 17.8°, 20.5° and 23.4°.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 17, 2013
From: ABBOTT LABORATORIES
To: ABBVIE INC.
Reel/Frame 030237/0588 →
CORRECTIVE ASSIGNMENT TO CORRECT THE <CONVEYING PARTIES> PREVIOUSLY RECORDED ON REEL 022155 FRAME 0233. ASSIGNOR(S) HEREBY CONFIRMS THE ADD <ALEXANDER F. CHU-KUNG>. Recorded Jul 22, 2010
From: CHU-KUNG, ALEXANDER F.; BORCHARDT, THOMAS B.
To: ABBOTT LABORATORIES
Reel/Frame 024725/0497 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 26, 2009
From: BORCHARDT, THOMAS B.
To: ABBOTT LABORATORIES
Reel/Frame 022155/0233 →